Home > Insider Trading > Filing (0001209191-23-003290)

Filing Details

Accession Number:: 0001209191-23-003290
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-13 16:34:06
Reporting Period:: 2023-01-11

Accepted Time:: 2023-01-13 16:34:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1697532	Applied Therapeutics Inc.	APLT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775490	Shoshana Shendelman	C/O Applied Therapeutics, Inc. 545 Fifth Avenue, Suite 1400 New York NY 10017	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-11	15,870	$0.91	751,625	No	4	S	Direct
Common Stock	Acquisiton	2023-01-11	1,964,362	$0.00	2,715,987	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,750,000	Indirect	See footnote
Common Stock	1,492,094	Indirect	See footnote
Common Stock	709,720	Indirect	See footnote
Common Stock	290,280	Indirect	See footnote
Common Stock	88,397	Indirect	See footnote

Footnotes

The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
Includes 1,725,000 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
Includes 239,362 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Restricted Stock Units to the reporting person in lieu of a cash bonus that otherwise would have been paid with respect to 2022. All of the shares subject to the compensatory Restricted Stock Units vested immediately upon grant.
Through a grantor retained annuity trust.
Through a family trust controlled by the reporting person's spouse.
Through the reporting person's spouse.
Through a family trust controlled by the reporting person.
Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.